Dr. Magali Cordaillat Simmons
Dr. Magali Cordaillat Simmons
Scientific and Regulatory Affairs Director
Pharmabiotic Research Institute (PRI)

Magali earned her PhD in Cardiovascular Pharmacology at Université Descartes - Paris, France, in 2005. She then worked as a Research Associate at the University of Virginia, USA, where she studied the influence of epigenetics on renin expression. She currently supervises the Association’s regulatory intelligence strategy so that “Microbiome-based Medicinal Products” (MMPs) become a therapeutic reality for European patients. The PRI is Europe’s first and only Microbiome Regulatory Science group dedicated to supporting its members in the development and registration of Microbiome-based Medicinal Products (MMPs). As a non-profit, Pro-industry organization, the PRI is uniquely positioned to both be a trusted point of contact for the European regulatory authorities, as well as an agile and neutral partner for the Microbiome/Health industries.